Home > Insider Trading > Filing (0001243764-10-000003)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
880771	Sciclone Pharmaceuticals Inc	SCLN	Pharmaceutical Preparations (2834)	943116852

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1243764	P Hans Schmid	950 Tower Lane Suite 900 Foster City CA 94404	Pres & Mng Dir, Sciclone Int'l	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-05-14	20,000	$1.81	20,000	No	4	M	Direct
Common Stock	Acquisiton	2010-05-14	35,000	$1.08	55,000	No	4	M	Direct
Common Stock	Disposition	2010-05-14	55,000	$3.84	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2010-05-14	20,000	$0.00	20,000	$1.81
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2010-05-14	35,000	$0.00	35,000	$1.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000		2018-03-18	No	4	M	Direct
90,000		2019-03-06	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8 to $3.89 inclusive.
Granted under the Issuer's 2005 Equity Incentive Plan.
25% of such shares vest one year from the date of grant, of March 18, 2008, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
25% of such shares vest one year from the date of grant, of March 6, 2009, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.